Creative Medical Technology Holdings, Inc.
CELZ
$2.14
$0.052.39%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 11.00K | 11.00K | 17.00K | 9.00K | 9.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.00K | 11.00K | 17.00K | 9.00K | 9.00K |
| Cost of Revenue | 4.40K | 4.40K | 6.80K | 3.60K | 3.60K |
| Gross Profit | 6.60K | 6.60K | 10.20K | 5.40K | 5.40K |
| SG&A Expenses | 3.24M | 3.24M | 3.28M | 3.46M | 3.56M |
| Depreciation & Amortization | 110.50K | 113.40K | 107.10K | 100.80K | 94.50K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.75M | 5.64M | 6.08M | 5.64M | 5.63M |
| Operating Income | -5.74M | -5.63M | -6.06M | -5.63M | -5.62M |
| Income Before Tax | -5.49M | -5.32M | -5.73M | -5.28M | -5.29M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.49 | -5.32 | -5.73 | -5.28 | -5.29 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.49M | -5.32M | -5.73M | -5.28M | -5.29M |
| EBIT | -5.74M | -5.63M | -6.06M | -5.63M | -5.62M |
| EBITDA | -5.63M | -5.52M | -5.96M | -5.53M | -5.53M |
| EPS Basic | -3.68 | -3.80 | -4.07 | -3.75 | -3.76 |
| Normalized Basic EPS | -2.30 | -2.38 | -2.55 | -2.34 | -2.35 |
| EPS Diluted | -3.68 | -3.80 | -4.07 | -3.75 | -3.76 |
| Normalized Diluted EPS | -2.30 | -2.38 | -2.55 | -2.34 | -2.35 |
| Average Basic Shares Outstanding | 5.92M | 5.60M | 5.64M | 5.64M | 5.63M |
| Average Diluted Shares Outstanding | 5.92M | 5.60M | 5.64M | 5.64M | 5.63M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |